
Delayed Herpes Zoster PseudodendritesPolymerase Chain Reaction Detection of Viral DNA and a Role for Antiviral Therapy
Deborah Pavan-Langston, MD;
Shuji Yamamoto, MD;
Edmund C. Dunkel, PhD
Arch Ophthalmol. 1995;113(11):1381-1385.
Abstract
 |  |
Background The late-onset pseudodendrites, delayed corneal mucous plaques, of herpes zoster ophthalmicus are reported to be of mechanical or immune origin and to be worsened by antiviral therapy.
Objective To study pseudodendrites to ascertain a viral presence in the lesions and their response to antiviral therapy.
Design Prospective clinical study.
Setting Outpatient and inpatient hospital-based corneal specialty referral practice; molecular virology laboratory.
Patients Six patients, aged 33 to 89 years, four with delayed herpes zoster ophthalmicus pseudodendrites and two with herpes zoster ophthalmicus neurotrophic ulceration. One patient was immunosuppressed.
Main Outcome Measures Findings from clinical evaluation; polymerase chain reaction assays of lesions and tear film of six patients; polymerase chain reaction and light and electron microscopy of the corneal button from one patient; and the clinical response of four patients to various antiviral drugs.
Results In contrast to reports in the current literature, delayed pseudodendrites may also be infectious, as they are positive for zoster DNA by polymerase chain reaction and appear responsive to certain antiviral therapy. The corneal button from an immunosuppressed patient had mature and immature viral particles in the basal cells within 2 weeks of transplantation.
Conclusions To our knowledge, this is the first report of viral DNA in delayed zoster pseudodendrites. Recurrent viral infection may play a role in this form of zoster keratopathy and warrant antiviral therapy.
Author Affiliations
From the Departments of Ophthalmology, Harvard Medical School, Boston, Mass (Drs Pavan-Langston, Yamamoto, and Dunkel) and Osaka (Japan) University Medical School (Dr Yamamoto), Massachusetts Eye and Ear Infirmary, Boston (Drs Pavan-Langston and Yamamoto), and Schepens Eye Research Institute, Boston (Drs Pavan-Langston, Yamamoto, and Dunkel). The authors and their families have no commercial or proprietary interest in any drug or company mentioned in this article.
CiteULike Connotea Del.icio.us Digg Reddit Technorati Twitter
What's this?
THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES
Acute, chronic, and recurrent varicella zoster virus neuropathy without zoster rash
Fox et al.
Neurology 2001;57:351-354.
ABSTRACT
| FULL TEXT
Human herpesviruses in the cornea
Kaye et al.
Br J Ophthalmol 2000;84:563-571.
ABSTRACT
| FULL TEXT
Chronic Varicella-zoster Virus Epithelial Keratitis in Patients With Acquired Immunodeficiency Syndrome
Chern et al.
Arch Ophthalmol 1998;116:1011-1017.
ABSTRACT
| FULL TEXT
Detection of Varicella-zoster Virus DNA in Keratectomy Specimens by Use of the Polymerase Chain Reaction
Mietz et al.
Arch Ophthalmol 1997;115:590-594.
ABSTRACT
The Use of Polymerase Chain Reaction Techniques to Detect Varicella-zoster Virus in Corneal Transplant Tissue
Liesegang
Arch Ophthalmol 1997;115:664-665.
ABSTRACT
|